Rowland Carmichael Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $797K | Sell |
13,680
-135
| -1% | -$7.87K | 0.25% | 92 |
|
|
2020
Q3 | $873K | Buy |
13,815
+80
| +0.6% | +$5.06K | 0.34% | 76 |
|
|
2020
Q2 | $1.06M | Sell |
13,735
-27
| -0.2% | -$2.08K | 0.45% | 49 |
|
|
2020
Q1 | $1.03M | Buy |
13,762
+75
| +0.5% | +$5.61K | 0.52% | 36 |
|
|
2019
Q4 | $889K | Sell |
13,687
-114
| -0.8% | -$7.41K | 0.31% | 90 |
|
|
2019
Q3 | $875K | Buy |
13,801
+201
| +1% | +$12.7K | 0.3% | 87 |
|
|
2019
Q2 | $919K | Hold |
13,600
| – | – | 0.32% | 78 |
|
|
2019
Q1 | $884K | Hold |
13,600
| – | – | 0.32% | 79 |
|
|
2018
Q4 | $851K | Hold |
13,600
| – | – | 0.38% | 52 |
|
|
2018
Q3 | $1.05M | Hold |
13,600
| – | – | 0.41% | 55 |
|
|
2018
Q2 | $963K | Hold |
13,600
| – | – | 0.41% | 56 |
|
|
2018
Q1 | $1.03M | Hold |
13,600
| – | – | 0.56% | 41 |
|
|
2017
Q4 | $974K | Sell |
13,600
-50
| -0.4% | -$3.58K | 0.5% | 54 |
|
|
2017
Q3 | $1.11M | Hold |
13,650
| – | – | 0.61% | 36 |
|
|
2017
Q2 | $966K | Hold |
13,650
| – | – | 0.56% | 47 |
|
|
2017
Q1 | $927K | Hold |
13,650
| – | – | 0.56% | 45 |
|
|
2016
Q4 | $977K | Hold |
13,650
| – | – | 0.58% | 53 |
|
|
2016
Q3 | $1.08M | Hold |
13,650
| – | – | 0.69% | 42 |
|
|
2016
Q2 | $1.14M | Hold |
13,650
| – | – | 0.72% | 33 |
|
|
2016
Q1 | $1.25M | Buy |
+13,650
| New | +$1.25M | 1.16% | 18 |
|